Rat Rena-strip lateral-flow strips

Kim-1 is a type I trans-membrane structural glycoprotein located in the renal proximal tubule epithelial cells. These cells undergo regeneration after various forms of injury and shed Kim-1 antigen into the urine. Thus, urinary Kim-1 is an early and specific biomarker for tubular kidney injury. Kim-1 has become widely recognized by many organizations and agencies, including the FDA, as an excellent biomarker in pre-clinical studies to monitor acute kidney tubular toxicity by identifying adverse reactive drugs and therapeutic agents in drug development.
Kidney injury caused by therapeutic agents and drug induction is a common type of injury requiring appropriate monitoring and intervention. Current standards using blood urea nitrogen and creatinine are considered late indicators of kidney injury and are often non-specific. Kim-1 has been shown continually to outperform traditional biomarkers of kidney injury in preclinical biomarker studies. The detection of Kim-1 can occur in as little as six hours post injection of an agent known to cause kidney injury.
The Rat Rena-strip test is a 15-minute qualitative (or quantitative with optional reader) lateral flow assay. Rat urine samples are added to the cassette and results can be read within 15 minutes.


Kit Contents:

Rat Rena-strip cassettes in white foil pouches with dessicant, 25 cassettes

7 x 5 x 4.5 in

Ambient

S.K. Bland, O. Cote, M.E. Clark, J. Delay, D. Bienzle. Characterization of Kidney Injury Molecule-1 in Cats. Journal of Veterinary Internal Medicine. 2014; 28(5):1454-1464.

Raymond J. Bergeron, Jan Wiegand, Neelam Bharti, James S. McManis, Shailendra Singh. Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity. Biometals. 2011; 24:239–258.

Raymond J. Bergeron, Jan Wiegand, James S. McManis, and Neelam Bharti. Desferrithiocin: A Search for Clinically Effective Iron Chelators. J. Med. Chem. 2014; 57 (22):9259–9291.

Raymond J. Bergeron, Jan Wiegand, Neelam Bharti, and James S. McManis. Substituent Effects on Desferrithiocin and Desferrithiocin Analogue Iron Clearing and Toxicity Profiles. J Med Chem. 2012; 55(16): 7090–7103.